O3-9-3Phase II study of trastuzumab with irinotecan in HER2-positive gastric cancer previously treated with trastuzumab
Hatanaka, Kazuteru, Kawamoto, Yasuyuki, Yuki, Satoshi, Meguro, Takashi, Uebayashi, Minoru, Abe, Masakazu, Nakamura, Michio, Okuda, Hiroyuki, Sakata, Yuh, Komatsu, YoshitoVolume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx697.083
Date:
October, 2017
File:
PDF, 79 KB
2017